Eric Pineda Lopez

Senior pharmaceutical executive with 25+ years building and leading high-performing commercial organizations across Mexico and Latin America.

Most recently as Business Unit Director at Amgen México — a role with full P&L ownership of a $130M business, leading a 65+ person cross-functional team across Sales, Marketing, and Market Access. Over four consecutive years, we delivered 40%+ growth and achieved market leadership in two of Mexico's most competitive therapeutic areas: PCSK9 inhibitors and Osteoporosis — both through disciplined brand strategy and excellence in execution.

What defines my career is not just the results — it's how they were built. I've been a builder at every stage: designed SFE frameworks from scratch at GSK for a 600+ rep field force, architected Amgen Mexico's commercial capabilities infrastructure, and scaled a distributor-led commercial model across 10 LATAM markets. Executive Committee member for 8+ years, contributing to enterprise-wide strategy, investment priorities, and organizational direction.

Core strengths: General Management · P&L Leadership · Commercial Strategy · Market Access · LATAM Operations · Organizational Leadership · Growth Transformation.

Open to senior commercial and general management opportunities in health, pharmaceutical, biotech, or consumer health industries across Mexico and Latin America. Also open to regional or cross-functional leadership roles where driving growth, building teams, and shaping strategy create long-term business value.

📩 ericplmx@gmail.com

Amgen México | 2013 – 2026

Business Unit Director | 2022 – May 2026

Commercial leadership role in Amgen México. Full P&L ownership of a $130M revenue business with 65+ cross-functional reports across Sales & Marketing— operating in both private and public sectors.

▸ Delivered 40% CAGR over four consecutive years, consistently outperforming category benchmarks and sustaining growth through market volatility and global organizational restructuring.

▸ Achieved leading market position in two of the most competitive therapeutic areas in Mexico: PCSK9 inhibitors (CV) and Osteoporosis — both gained through disciplined brand strategy and excellence in execution.

▸ Built and retained a high-performing team of 65+, maintaining execution quality and morale through a period of significant global change.

▸ Served as Executive Committee member, shaping investment priorities, compliance execution, organizational design, and multi-year strategic direction at the enterprise level.

▸ Secured and optimized resource allocation across channels and therapeutic areas, maximizing return on investment and long-term pipeline positioning.

Commercial Director – LATAM Distributors | 2019 – 2022

Led commercial operations across a 10-country by distributor model in Latin America, managing P&L, governance, and go-to-market execution.

▸ Delivered 12% CAGR across the region, expanding market footprint and growing revenue in underpenetrated markets.

▸ Executed 20+ product launches across LATAM, adapting global strategy to local market dynamics across diverse regulatory and payer environments.

▸ Built and governed a distributor-based commercial model, standardizing KPIs, incentive structures, and performance reporting across 10 countries.

▸ Strengthened cross-functional alignment between global headquarters and local affiliates, accelerating launch timelines and commercial readiness.

Commercial Excellence Director | 2015 – 2019

Architect of Amgen Mexico's commercial capabilities infrastructure, overseeing Business Intelligence, SFE, Training, Patient Support Programs, and Market Insights.

▸ Designed and deployed the integrated commercial capabilities framework that supported 5+ years of consistent double-digit growth.

▸ Led market insights function that shaped brand positioning, pricing strategy, and portfolio prioritization at executive level.

▸ Built Patient Support Programs (PSP) that enhanced patient access and adherence, contributing to market share gains.

Sales Force Effectiveness Manager | 2013 – 2015

▸ Built the SFE function from ground zero, establishing frameworks for segmentation, targeting, and field force productivity that became the commercial foundation for subsequent growth.

Grünenthal México | 2012 – 2013

Project Leader – Sales Force Optimization | 2012 – 2013

▸ Redesigned salesforce size, structure, and territory alignment, improving field productivity and coverage efficiency across key therapeutic areas.

GlaxoSmithKline México | 2001 – 2012

Market Research Manager & SFE Lead | 2001 – 2012

11 years of progressive responsibility across commercial excellence, market research, and sales force effectiveness in one of the world's leading pharmaceutical companies.

▸ Designed and implemented individual scorecards for 600+ sales representatives across multiple therapeutic areas, enabling data-driven performance management at scale.

▸ Created a Sales Force Performance Index — a proprietary composite metric that standardized recognition and incentive allocation across the national field force, adopted as a best practice within GSK Mexico.

▸ Built Amgen's targeting model from scratch, defining segmentation criteria and call prioritization logic that increased field force efficiency and prescription impact.

▸ Led market research initiatives that informed brand strategy, competitive positioning, and portfolio investment decisions across multiple therapeutic areas.

EDUCATION

MBA (In Progress, est. 2026–2027) – Universidad del Valle de México

B.A. Business Administration – Universidad del Valle de México

LANGUAGES

Spanish: Native English: Advanced — business fluent in negotiations, executive presentations, and cross-functional global collaboration.

CORE COMPETENCIES

P&L Leadership | Business Strategy | LATAM Operations | Commercial | Excellence | General Management | Market Access | Organizational Leadership | Growth | Transformation | Sales Force Effectiveness | Market Insights | Distributor Management | Product Launch Excellence